Martha Grogan, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Martha Grogan, MD

Martha Grogan, MD

Healthcare Professional
Consultant
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States
Martha Grogan is a Cardiologist-Internist at Mayo Clinic, Rochester, Minnesota.  She completed her graduation with distinction in Biology from University of Cincinnati and MD from Northwestern University Feinberg School of Medicine. She completed her Residency in Internal medicine and Fellowships in cardiovascular diseases and adult congenital heart disease from Mayo Graduate School of Medicine, Mayo Clinic College of Medicine.
 
Dr. Grogan has an experience in treating conditions like cardiac amyloidosis, cardiomyopathy and heart failure. She has special interests in amyloid heart disease, echocardiography, reversible cardiomyopathies and health education to the general public. Currently Dr. Grogan is a member of Scientific Advisory Board of Transthyretin Amyloidosis Outcomes Survey (THAOS), International Society of Amyloidosis and Health Information Service Line (HISL) Coordinating Board (Mayo Clinic Rochester Committees).
 
Martha Grogan has been a Founder and Director of the Cardiac Amyloid Clinic and Former Chief of Internal Medicine and Medical Director, Assistant Warden, at the Federal Medical Center. Besides, she was on staff at Kaiser Permanente Sunnyside in Portland Oregon before joining the Mayo Clinic staff in 1995 and has been the cardiovascular medical editor of the award-winning MayoClinic.com website for almost a decade. Dr Grogan conducts clinical research with a focus on cardiac amyloidosis and lectures widely.
 
 
Representative Publications:
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close